Recursion Pharmaceuticals is back in focus after analysts adjusted their price target to US$5.90, following earlier updates ...

What you will learn in this article・What the 9 Japanese stocks, US stocks, and crypto assets riding the structural changes of ...

Recursion Pharmaceuticals is maintained at a "Hold" rating, pending further regulatory clarity and late-stage trial ...

In his celebrated short stories about robots, science fiction author Isaac Asimov devised three laws to prevent machines from ...

If AI evolves, won't drug discovery become more successful?I have high expectations for the future. Beyond obesity and lifestyle-related diseases, this could provide new options for people who are not ...

Appearing at the Minnesota Star Tribune's North Star Summit, OpenAI's Varun Shetty addressed AI, the media and calls for a slowdown in development.

"We really do earnestly believe AI could kill all humans!" added Evan Hubinger, who leads a department at Anthropic focused on ensuring AI acts the way its creators intend. "Unless there is AI ...

The president said the U.S. is leading China in AI by roughly a year, while researchers at Anthropic and OpenAI have warned of catastrophic risk ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...